The Evolving Management of Unstable Coronary Artery Disease and Its Impact on Practice Outwith the Tertiary Hospital

Abstract

Get full access to this article

View all access options for this article.

References

Graff

Dallara

Ross

. Impact on the care of the emergency department chest pain patient from the Chest Pain Evaluation Registry (CHEPER) Study. Am J Cardiol 1997; 80:563–8.

Vanmiltenburg

AJM

Simoons

Veerhoek

Bossuyt

PMM

. Incidence and follow up of Braunwald sub groups in unstable angina pectoris. J Am Coll Cardiol 1995; 25:1286–92.

Rizik

Healy

Margulis

. A new clinical classification for hospital prognosis of unstable angina. Am J Cardiol 1995; 75:993–7.

Rupprecht

Sohn

Kearney

. Clinical predictors of unstable coronary lesion morphology. Eur Heart J 1995; 16:1526–34.

Dangas

Mehran

Wallenstein

. Correlation of angiographic morphology and clinical presentation in unstable angina. J Am Coll Cardiol 1997; 29:519–25.

Owa

Origasa

Saito

. Predictive validity of the Braunwald Classification of unstable angina for angiographic findings, short term prognoses, and treatment selection. Angiology 1997; 48:663–71.

Cannon

McCabe

Stone

. The electrocardiogram predicts one year outcome of patients with unstable angina and non Q wave myocardial infarction: Results of the TIMI III registry ancillary study. J Am Coll Cardiol 1997; 30:133–40.

Patel

Holdright

Knight

. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996; 75:222–8.

Stevenson

Marchant

Ranjadayalan

. Holter ST monitoring early after acute myocardial infarction - mechanisms of ischaemia in patients treated by thrombolysis. Br Heart J 1993; 70:433–7.

10.

Summaria

Liuzzo

Petrone

. Increased levels of C-reactive protein and serum amyloid A protein are related to a raised risk of new coronary events within one year in patients with unstable angina. Circulation 1997; 96:1270.

11.

Oltrona

Ardissino

Merlini

. C reactive protein elevation and early outcome in patients with unstable angina pectoris. Am J Cardiol 1997; 80:1002–6.

12.

Noto

Johnson

Krone

. Cardiac catheterization 1990: a report of the Registry of the Society of Cardiac Angiography and Interventions. Cathet Ccardiovasc Diagn 1991; 24:75–83.

13.

de Bono

. Complications of diagnostic cardiac catheterisation: results from 34,041 patients in the United Kingdom confidential inquiry into cardiac catheter complications. Br Heart J 1993; 70:297–300.

14.

Kern

. Selection of radiocontrast media in cardiac catheterisation: comparative physiology and clinical effects of nonionic monomeric and ionic dimeric formulations. Am Heart J 1991; 122:195–201.

15.

Pasternak

Thibault

Savoia

. Chest pain with angiographically insignificant arterial obstruction: clinical presentation and long term follow up. Am J Med 1980; 68:813–7.

16.

Pitts

Lange

Cigarroa

Hillis

. Repeat coronary angiography in patients with chest pain and previously normal coronary angiogram. Am J Cardiol 1997; 80:1086–7.

17.

Oler

Whooley

Oler

Grady

. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina - a meta analysis. J Am Med Assoc 1996; 276:811–5.

18.

Serneri

GGN

Modesti

Gensini

. Randomized comparison of subcutaneous heparin, intravenous heparin and aspirin in unstable angina. Lancet 1995; 345:1201–4.

19.

Cohen

Demers

Gurfinkel

. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary disease. N Engl J Med 1997; 337:447–52.

20.

Klein

Buchwald

Hillis

. Comparison of low molecular weight heparin acutely with placebo for six weeks in the management of unstable coronary artery disease - Fragmin in unstable coronary artery disease study (FRIC). Circulation 1997; 96:61–8.

21.

Grip

Frison

Wallentin

. A low molecular weight selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease. Eur Heart J 1997; 18:1416–25.

22.

Wallentin

Ohlsson

Swahn

. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347:561–8.

23.

Mark

Cowper

Berkowitz

. Economic assessment of low molecular weight heparin (Enoxaparin) versus unfractionated heparin in acute coronary syndrome patients. Circulation 1998; 97:1702–7.

24.

Fuchs

Cannon

Braunwald

, TIMI 7 Investigators Hirulog in the treatment of unstable angina: results of the Thrombin Inhibition in Myocardial ischaemia (TIMI) 7 Trial. Circulation 1995; 92:727–33.

25.

Antman

. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B Trial. Circulation 1996; 94:911–21.

26.

Topol

Califf

Granger

. A comparison of recombinant hirudin with heparin for the treatment of acute coronary symdromes. New Engl J Med 1996; 335:775–82.

27.

Bata

MacFarlane

Campeau

. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischaemia without ST elevation - a pilot study. Circulation 1997; 96:769–77.

28.

Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I Prevention of death myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81–106.

29.

Schafer

. Antiplatelet therapy. Am J Med 1996; 101:199–209.

30.

Wheeldon

Cumberland

. Pharmcologic prevention of acute ischemic complications of coronary angioplasty. Cathet Cardiovasc Diagn 1997; 42:249–56.

31.

Born

GVR

Collins

. Aspirin versus clopidogrel: the wrong question? Lancet 1997; 349:806–7.

32.

Gent

Beaumont

Blanchard

. A randomized blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348:1329–39.

33.

Coller

Anderson

Weisman

. The anti GPIIb/IIIa agents: fundamental and clinical aspects. Haemostasis 1996; 26:285–93.

34.

Theroux

Fung

Boudreault

. Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina - The Canadian Lamifiban study. Circulation 1996; 94:899–905.

35.

Pepine

Cohn

Deedwania

. Effects of treatment on outcome in mildly symptomatoc patients with ischaemia during daily life. The Atenolol Silent Ischaemia Study (ASSIST). Circulation 1994; 90:762–8.

36.

Grundy

. Statin trials and goals of cholesterol lowering therapy. Circulation 1998; 97:1436–9.

37.

Gotto AM AFCAPS/TEXCAPS Interim Study results. American Heart Association, November 1997

38.

Tonkin

. LIPID Interim Study results. American Heart Association, November 1997.

39.

Andrews

Raby

Barry

. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 1997; 95:324–8.

40.

McCormick

Black

Waters

. Rationale, design and baseline characteristics of a trial comparing agressive lipid lowering with atorvastatin versus revascularization treatments (AVERT). Am J Cardiol 1997; 80:1130–3.

41.

Braunwald

McCabe

Cannon

. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non Q wave myocardial infarction: results of the TIMI III B Trial. Circulation 1994; 89:1545–56.

42.

Rickards

Ilsley

Simon

. First year results of CABRI. Lancet 1995; 346:1179–84.

43.

Hlatky

Rogers

Johnstone

. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997; 336:92–9.

44.

Boden

O'Rouke

Dai

. Improved clinical outcomes in non Q wave infarction patients randomized to a conservative ischemia guided strategy compared to an invasive/interventional strategy: results of the multicenter VA non Q wave infarction strategies in hospital (VANQWISH) trial. Circulation 1997; 96:1145.

45.

Sigwart

. Joint AHA/ESC symposium: new insights into unstable angina and non ST elevation - results of treatment by PTCA and CABG, Plenary Session III 70th Scientific Sessions of the American Heart Association, Orlando Fl. November 1997.

46.

Parker

Gray

Balcon

. Planning for coronary angioplasty: guidelines for training and continuing competence. Heart 1996; 75:419–25.